Search
Clinician Ordering Portal
Resources
Scientific references
DiffDx-Melanoma is clinically validated to aid dermatopathologists in difficult-to-diagnose melanocytic lesions
Publications
DiffDx-Melanoma Clinical Utility Studies
- Farberg AS, Ahmed KL, Bailey CN, et al. A 35-gene expression profile test for use in suspicious pigmented lesions impacts clinical management decisions of dermatopathologists and dermatologists. SKIN: J Cutan Med 2020 4(6), 523-533.
- Estrada SI, Shackelton JB, Cleaver NJ, et al. Development and validation of a diagnostic 35-gene expression profile test for ambiguous or difficult-to-diagnose suspicious pigmented skin lesions. SKIN: J Cutan Med 2020 4(6), 506-522.